LabPulse.com
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
  • Sign In
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Stay in the Know
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
I have read and agree to the privacy policy & terms of service and wish to opt-in.
Business Insights
  • Policy & Regulation
  • Trends & Finance
Research & Development
  • Clinical Trials
  • Collaboration
  • Funding
Diagnostic Technologies
  • Clinical Chemistry
  • Emerging Technology
  • Immunoassays
  • Molecular Diagnostics
  • Pathology & AI
Diseases
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
User Tools
  • Sign In
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon
  • Business Insights
    • Policy & Regulation
    • Trends & Finance
  • Diagnostic Technologies
    • Clinical Chemistry
    • Emerging Technology
    • Immunoassays
    • Molecular Diagnostics
    • Pathology & AI
  • Diseases
    • Autoimmune
    • Cancer
    • Cardiovascular
    • COVID-19
    • Health Topics
    • Infectious
  • Point-of-Care Testing
  • Research & Development
    • Clinical Trials
    • Collaboration
    • Funding
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
  • Sign In
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon

Brian Casey

[email protected]
Microbiology
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
May 25, 2021
Infectious
AACC moves annual meeting from Anaheim to Atlanta
On the other hand, the convention center in Atlanta is open and is already holding large meetings, Grenache said. The facility has implemented a number of safety protocols, including programs for cleaning, disinfection, and infectious disease prevention with "highly informed" cleaning professionals who are trained for outbreak and infectious disease preparation and response.
March 17, 2021
2019 08 05 17 59 6641 Aacc 2019 400
Microbiology
LabPulse.com Microbiology Insider
Dear Microbiology Insider,
February 23, 2021
Home
FDA commissioner Hahn leaves agency
Hahn's departure was reported in the news media on January 19, and it was confirmed by the FDA in a tweet on January 20, the same day that President Joe Biden was sworn in. Woodcock is currently head of the FDA's Center for Drug Evaluation and Research (CDER).
January 19, 2021
2021 01 20 21 45 6852 Hahn Stephen 400
Moderate Complexity Test
FDA commissioner Hahn leaves agency
Hahn's departure was reported in the news media on January 19, and it was confirmed by the FDA in a tweet on January 20, the same day that President Joe Biden was sworn in. Woodcock is currently head of the FDA's Center for Drug Evaluation and Research (CDER).
January 19, 2021
2019 11 01 22 16 2253 Hahn Stephen 20191101221734
Infectious
AACC sets 2021 meeting for Anaheim in September
Like nearly all trade conferences since March, the AACC was forced to postpone its 2020 meeting due to the COVID-19 pandemic. The conference was originally scheduled to take place in Chicago in August 2020, but then was pushed back to December 13-17. Ultimately, the group decided to hold the show virtually.
December 9, 2020
2020 12 15 16 56 3318 Lab Scientists Diverse 400
Diagnostic Technologies
LabPulse.com Lab Analyzers Insider
Dear Lab Analyzers Insider,
November 22, 2020
Influenza
LabPulse.com Point-of-Care Insider
Dear Point-of-Care Insider,
November 8, 2020
Microbiology
LabPulse.com Microbiology Insider
Diagnostic testing is key to controlling the COVID-19 pandemic, and the earlier that SARS-CoV-2 infection can be detected, the better. Researchers from Hong Kong believe they may have found an assay that detects SARS-CoV-2 at a much earlier stage of infection.
October 25, 2020
Point-of-Care Testing
LabPulse.com Point-of-Care Insider
Dear Point-of-Care Insider,
August 23, 2020
Previous Page
Page 2 of 6
Next Page
Top Stories
Heart Pulmonary Trunk Social
Coronary Artery Disease
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
Stock Exchange Social
Stock
Nasdaq issues delisting notice to T2 Biosystems
Sepsis Bacteria Social
Sepsis
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Colorectal Cancer Social
Collaboration
Universal DX partners with Quest Diagnostics, closes $70M series B financing round
Liver Anatomy Social
Synthetic Biology
Bit.bio unveils cell therapy candidate for liver conditions
More in Home
FDA plans to increase oversight of LDTs garner strong response
Plans to increase U.S. Food and Drug Administration (FDA) oversight of laboratory-developed tests (LDTs) have drawn a strong response from trade groups, individuals, and organizations.
November 17, 2023
Fda Sign Dc Social
Cytovale raises $84M in series C funding
Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.
November 16, 2023
Money Hundred Bills Social
Zymo Research, Ad Astra Diagnostics receive FDA 510(k) clearances
Molecular diagnostics firm Zymo Research and rapid diagnostics developer Ad Astra Diagnostics have both received 510(k) clearances from the U.S. Food and Drug Administration.
November 16, 2023
Fda Button Social
Networks of wearable sensors capture body sounds to improve patient monitoring
Researchers have developed soft, miniaturized wearable devices to continuously capture the sounds of breathing and other bodily functions.
November 16, 2023
A health care worker places the wearable devices across a patient's chest to capture sounds throughout the lungs that are associated with breathing. Photo courtesy of Northwestern University.
AnchorDx, DiaCarta to collaborate on cancer diagnostics
Biotech company AnchorDx has entered into a long-term partnership with molecular diagnostics firm DiaCarta to develop and commercialize cancer diagnostic products for the global market.
November 14, 2023
Hands Shaking Deal Social
Talis Biomedical to lay off 90% of workforce, pursue strategic alternatives
POC testing company Talis Biomedical has announced that it will lay off 90% of its employees and has begun exploring strategic alternatives.
November 15, 2023
Layoff Woman Belongins
AI model shows promise detecting COVID-19 in low-resource settings
An artificial intelligence (AI) model shows promise for diagnosing COVID-19 in low-resource settings with severe shortages of medical experts, including in many African regions, according to a study published November 11 in Scientific Reports.
November 14, 2023
Artificial Intelligence Ai Hand Social
Jury finds Guardant Health liable for $83.4M in patent infringement lawsuit
A jury in the U.S. District Court for the District of Delaware found that Guardant Health infringed on patents held by TwinStrand Biosciences and licensed to the University of Washington.
November 15, 2023
Gavel Scale Lawsuit
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Molecule Social
Illumina launches pricing program for pathogen sequencing tools in LMICs
Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).
November 13, 2023
Infectious Diseases Research Social
Fragment of C. diff toxin shows preclinical promise as breast cancer treatment
A fragment of a Clostridium difficile toxin could improve outcomes in patients with hard-to-treat forms of breast cancer, according to a paper published in PLOS Biology.
November 13, 2023
Bacteria Microscope Social
FDA grants approval to Takeda’s metastatic colorectal cancer therapy
The U.S. Food and Drug Administration (FDA) has approved a chemotherapy-free oral target therapy for patients who have been previously treated for metastatic colorectal cancer (mCRC).
November 9, 2023
Fda Button Social
Previous Page
Page 2 of 100
Next Page
LabPulse.com
Topics
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Whitepapers
  • Advertising
Follow LabPulse.com
Facebook iconTwitter X icon LinkedIn icon
  1. Privacy Policy
  2. Contact Us
  3. Site Map
© 2023 Science and Medicine Group. All rights reserved.